We live in a world where $1 billion of prescription medications are left at the pharmacy counter each year, often because ...

Typically, Ozempic is covered by insurers only when it is prescribed as indicated for people with Type 2 diabetes. In other words, patients who are using it to shed extra pounds must pay out-of ...

Ozempic, an injection that keeps blood sugar levels in check for patients with Type 2 diabetes, has been in shortage for about four months, according to the database maintained by the U.S. Food ...

Ozempic, known generically as semaglutide, is one of a class of diabetes drugs known as GLP-1 receptor agonists that have been around for nearly two decades. It was first approved in the U.S. in ...

Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a ...

The desire for these drugs, which are remarkably effective at treating diabetes and obesity, has been nothing short of explosive. During the last three months of 2022, health-care providers wrote ...

Ozempic may have serious side effects, including thyroid cancer and problems with the pancreas, gallbladder, kidneys, and ...

which shortly followed Ozempic, the same technology marketed for diabetes treatment, in 2017 – the company’s most tenacious rival, Eli Lilly, quickly caught up. Its own weight-loss drug, Mounjaro, was ...

The use of hyaluronic acid fillers has meanwhile doubled from 2.6 million Americans in 2017 — the year Ozempic was first cleared for diabetes — to over 5.2 million in 2023.